4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-23-038885
EVP & Chief Commercial Officer sold 305 shares at $48.20 ($14,701)
From the SEC's structured data for this filing
Trades in this filing
Harris Erik · EVP & Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-06-19 | Sale : show line 1 in the form | −305 | $48.20 | $14,701 | 57,281 | D |
| Open-market sales · 305 sh · avg $48.20 · $14,701 | ||||||
Loading xslF345X04/doc4.xml…